| PDB ID | Description | |
|---|---|---|
![]() |
1SP5 | Crystal structure of HIV-1 protease complexed with a product of autoproteolysis |
![]() |
2NXL | Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA |
![]() |
1MT7 | Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy |
![]() |
2FNT | Crystal structure of a drug-resistant (V82A) inactive (D25N) HIV-1 protease complexed with AP2V variant of HIV-1 NC-p1 substrate. |
![]() |
1TSQ | CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT |
![]() |
2NXM | Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA |
![]() |
1MT8 | Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy |
![]() |
1TSU | CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT |
![]() |
1F7A | HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE. |
![]() |
1MT9 | Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy |